Rapid Dose Therapeutics Corp.
RDTCF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$12.28M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $12.28 Million |
|---|---|
| Enterprise Value | $18.07 Million |
| Earnings per Share | $-0.03 |
| Beta | -4.25 |
| Outstanding Shares | 136,337,569 |
Return
| Return on Equity | 42.04% |
|---|---|
| Return on Assets | -101.51% |
| Return on Invested Capital | 33.87% |
Valuation & Multiples
| P/E Ratio | -3.78 |
|---|---|
| PEG | 12.44 |
| Price to Sales | - |
| Price to Book Ratio | -0.06 |
| Enterprise Value to Revenue | 7.02 |
| Enterprise Value to EBIT | -9.54 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.32 |
| Debt to Equity | -0.77 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Rapid Dose Therapeutics Corp.
12 employees
CEO: Mark Andrew Upsdell
Rapid Dose Therapeutics Corp., headquartered in Burlington, Canada, is a life sciences enterprise dedicated to developing advanced drug delivery technologies aimed at improving health results and individuals' quality of life. The company...